Prostate Cancer Clinical Trial
Improving Germline Testing in At-Risk Patients With Prostate Cancer
A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.
This is a prospective single arm quality improvement initiative for the use of a standardized educational intervention on germline testing in prostate cancer to improve the rates of germline genetic testing among patients recommended for testing. Patients who consent to the study will undergo a one-on-one education session regarding the rationale and the benefits/risks of germline testing. Following the educational session, if a patient wishes to proceed with testing, they will sign the standard consent to proceed with germline testing via a commercial assay.
Men, age greater than or equal to 18 years of age.
Diagnosis of prostate cancer of any histology.
Must meet NCCN guidelines for germline testing
Have had prior germline testing.
Have somatic genetic testing that is positive for a possible germline variant.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.